Warrior
Warrior, licence 80120672: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Praesidio Health Inc.
- NPN or DIN-HM
- 80120672
- Status
- Active licence
- Licence date
- 19 August 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 20 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 1,000 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol | 250.0 UI | 25 µg |
| Vitamine D Source : Cholécalciférol | 6.25 microgram | 25 µg |
| Zinc Source : Citrate de zinc | 5.0 mg | 20,000 µg |
| Cuivre Source : Citrate de cuivre (II) | 0.25 mg | 1,000 µg |
| Vitamine C Source : Acide ascorbique | 250.0 mg | 1,000,000 µg |
| Composé corrélé d'hexose actif Source : Lentinula edodes - Mycélium | 250.0 mg | Not calculated |
| Aristotelia chilensis Source : Aristotelia chilensis - Fruit | 50.0 mg | Not calculated |
| Sambucus nigra subsp. nigra Source : Sambucus nigra subsp. nigra - Fruit Extract : Matériel brut sec Extraction ratio : 8.000:1 Dry plant equivalent : 400 mg | 50.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hypromellose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Sambucus nigra subsp. nigra is traditionally used in Herbal Medicine to promote sweating (diaphoretic), to help relieve fever (in cases of the common cold, flus) and to help relieve symptoms of colds and flus (such as coughs, sore throat and mucus buildup (catarrh) of the upper respiratory tract). Source of/Provides antioxidants. Helps (to) maintain/support immune function. Helps (to) maintain/support immune function/system. Helps with immune function. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80120672
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.